Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-1.72%
↑ 71% above average
Average (9y)
-5.99%
Historical baseline
Range
High:34.83%
Low:-123.88%
CAGR
-19.1%
Structural decline
| Period | Value |
|---|---|
| 2024 | -1.72% |
| 2023 | 34.83% |
| 2022 | 27.64% |
| 2021 | -9.82% |
| 2020 | 10.40% |
| 2019 | -5.93% |
| 2018 | -4.42% |
| 2017 | 24.67% |
| 2016 | -123.88% |
| 2015 | -11.67% |